-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Maintains Buy on Roivant Sciences, Raises Price Target to $52

Benzinga·09/08/2026 15:45:07
Listen to the news
Jefferies analyst Dennis Ding maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $42 to $52.